SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-005435
Filing Date
2020-05-06
Accepted
2020-05-06 16:49:02
Documents
59
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q morf-20200331x10q.htm 10-Q 1930614
2 EX-3.2 morf-20200331ex324625bcf.htm EX-3.2 212263
3 EX-31.1 morf-20200331ex311fb2e86.htm EX-31.1 14563
4 EX-31.2 morf-20200331ex31295ffb3.htm EX-31.2 14756
5 EX-32.1 morf-20200331ex3216cf023.htm EX-32.1 8586
6 EX-32.2 morf-20200331ex322af6c91.htm EX-32.2 7777
  Complete submission text file 0001558370-20-005435.txt   5834328

Data Files

Seq Description Document Type Size
7 EX-101.INS morf-20200331.xml EX-101.INS 1019260
8 EX-101.SCH morf-20200331.xsd EX-101.SCH 29002
9 EX-101.CAL morf-20200331_cal.xml EX-101.CAL 41189
10 EX-101.DEF morf-20200331_def.xml EX-101.DEF 157398
11 EX-101.LAB morf-20200331_lab.xml EX-101.LAB 345331
12 EX-101.PRE morf-20200331_pre.xml EX-101.PRE 280288
Mailing Address 35 GATEHOUSE DRIVE A2 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE A2 WALTHAM MA 02451 9787296480
Morphic Holding, Inc. (Filer) CIK: 0001679363 (see all company filings)

IRS No.: 473878772 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38940 | Film No.: 20853299
SIC: 2834 Pharmaceutical Preparations